HomeZURA • NASDAQ
Zura Bio Ltd
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 19.25M | 129.79% |
Net income | -17.44M | -125.15% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -19.25M | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 170.57M | 89.91% |
Total assets | 172.50M | 90.64% |
Total liabilities | 21.09M | 29.64% |
Total equity | 151.40M | — |
Shares outstanding | 61.87M | — |
Price to book | 0.51 | — |
Return on assets | -27.35% | — |
Return on capital | -30.91% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -17.44M | -125.15% |
Cash from operations | -11.06M | -122.06% |
Cash from investing | -49.00K | 99.02% |
Cash from financing | 5.18M | — |
Net change in cash | -5.93M | 40.64% |
Free cash flow | -5.73M | 56.21% |
Previous close
$1.04
Day range
$1.00 - $1.05
Year range
$0.97 - $5.82
Market cap
62.80M USD
Avg Volume
427.57K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2022
Website
Employees
30